NCT01520415View on ClinicalTrials.gov

Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Low Back Pain
Interventions
DRUG

Bupivacaine

2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit

DRUG

Saline

2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit

Trial Locations (1)

H3G 1A4

Alan Edwards Pain Management Unit - Montreal General Hospital, Montreal

All Listed Sponsors
lead

Dr. Yoram Shir

OTHER

NCT01520415 - Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients | Biotech Hunter | Biotech Hunter